Profile data is unavailable for this security.
About the company
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
- Revenue in JPY (TTM)997.33bn
- Net income in JPY117.80bn
- Incorporated1919
- Employees29.30k
- LocationOlympus Corp2951, Ishikawa-machiHACHIOJI-SHI 192-8507JapanJPN
- Phone+81 426422111
- Fax+81 333402062
- Websitehttps://www.olympus.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sysmex Corp | 508.64bn | 53.67bn | 1.57tn | 10.53k | 29.06 | 3.36 | 17.00 | 3.10 | 86.07 | 86.07 | 815.75 | 743.71 | 0.7922 | 2.94 | 3.09 | 48,290,420.00 | 8.34 | 8.70 | 10.29 | 10.94 | 53.47 | 52.47 | 10.53 | 10.98 | 2.30 | 10.86 | 0.1235 | 38.11 | 10.21 | 10.99 | 8.12 | 9.00 | 13.54 | 5.92 |
| Fisher & Paykel Healthcare Corporatn Ltd | 179.10bn | 33.43bn | 1.85tn | 7.51k | 55.75 | 11.04 | 40.38 | 10.33 | 0.6389 | 0.6389 | 3.42 | 3.23 | 0.8364 | 2.26 | 7.19 | 269,251.30 | 15.61 | 15.58 | 19.11 | 18.80 | 62.88 | 61.70 | 18.66 | 18.46 | 1.18 | 80.89 | 0.075 | 58.59 | 15.96 | 9.85 | 184.46 | 5.60 | -9.61 | 9.10 |
| Cochlear Ltd | 223.96bn | 35.94bn | 1.93tn | 5.00k | 53.79 | 10.63 | 43.51 | 8.60 | 5.64 | 5.64 | 35.15 | 28.54 | 0.8686 | 1.43 | 4.87 | 461,780.00 | 13.94 | 8.55 | 17.76 | 11.15 | 75.75 | 75.05 | 16.05 | 11.98 | 1.52 | -- | 0.1166 | 91.14 | 15.47 | 9.40 | 18.70 | 5.22 | -4.76 | 4.44 |
| Olympus Corp | 997.33bn | 117.80bn | 1.94tn | 29.30k | 16.53 | 2.56 | 10.55 | 1.95 | 103.21 | 103.27 | 870.68 | 666.54 | 0.6723 | 1.66 | 4.96 | 34,042,120.00 | 7.94 | 6.74 | 11.17 | 9.51 | 68.55 | 66.85 | 11.81 | 10.69 | 1.16 | 63.11 | 0.2336 | 21.13 | 6.53 | 5.72 | 342.69 | 14.22 | -0.2194 | 14.87 |
| Shanghai United Img Hlthcare Co Ltd | 214.43bn | 26.09bn | 2.13tn | 8.17k | 81.13 | 5.10 | -- | 9.92 | 1.55 | 1.55 | 12.73 | 24.61 | 0.3848 | 1.04 | 2.39 | 1,275,857.00 | 4.60 | 8.24 | 6.05 | 11.87 | 48.07 | 48.34 | 11.94 | 16.40 | 2.00 | -- | 0.0595 | 7.41 | -9.73 | 28.16 | -36.08 | -- | 24.57 | -- |
Data as of Jul 11 2025. Currency figures normalised to Olympus Corp's reporting currency: Japanese Yen JPY
31.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 03 Jul 2025 | 74.70m | 6.56% |
| Baillie Gifford & Co.as of 31 Mar 2025 | 65.60m | 5.76% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 38.95m | 3.42% |
| Nikko Asset Management Co., Ltd.as of 04 Jul 2025 | 36.76m | 3.23% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 34.33m | 3.01% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 26.88m | 2.36% |
| BlackRock Fund Advisorsas of 03 Jul 2025 | 23.37m | 2.05% |
| Dodge & Coxas of 31 Mar 2025 | 22.29m | 1.96% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Jul 2025 | 19.27m | 1.69% |
| MFS International Singapore Pte Ltd.as of 31 May 2025 | 16.70m | 1.47% |
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
